|Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma|
Y Chang, E Cesarman, MS Pessin, F Lee, J Culpepper, DM Knowles, ...
Science 266 (5192), 1865-1869, 1994
|Kaposi's sarcoma–associated herpesvirus-like DNA sequences in AIDS-related body-cavity–based lymphomas|
E Cesarman, Y Chang, PS Moore, JW Said, DM Knowles
New England Journal of Medicine 332 (18), 1186-1191, 1995
|Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus|
RG Nador, E Cesarman, A Chadburn, DB Dawson, MQ Ansari, J Sald, ...
|G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator|
C Bais, B Santomasso, O Coso, L Arvanitakis, EG Raaka, JS Gutkind, ...
Nature 391 (6662), 86-89, 1998
|Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation|
L Arvanitakis, E Geras-Raaka, A Varma, MC Gershengorn, E Cesarman
Nature 385 (6614), 347-350, 1997
|Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.|
PS Moore, SJ Gao, G Dominguez, E Cesarman, O Lungu, DM Knowles, ...
Journal of virology 70 (1), 549-558, 1996
|Kaposi's sarcoma and its associated herpesvirus|
EA Mesri, E Cesarman, C Boshoff
Nature Reviews Cancer 10 (10), 707-719, 2010
|Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders|
DM Knowles, E Cesarman, A Chadburn, G Frizzera, J Chen, EA Rose, ...
|In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated …|
E Cesarman, PS Moore, PH Rao, G Inghirami, DM Knowles, Y Chang
|Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus|
O Flore, S Rafii, S Ely, JJ O'Leary, EM Hyjek, E Cesarman
Nature 394 (6693), 588-592, 1998
|Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the …|
L Arvanitakis, EA Mesri, RG Nador, JW Said, AS Asch, DM Knowles, ...
|Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS …|
LD Kaplan, JY Lee, RF Ambinder, JA Sparano, E Cesarman, A Chadburn, ...
Blood 106 (5), 1538-1543, 2005
|Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.|
E Cesarman, RG Nador, F Bai, RA Bohenzky, JJ Russo, PS Moore, ...
Journal of virology 70 (11), 8218-8223, 1996
|HIV-associated lymphomas and gamma-herpesviruses|
A Carbone, E Cesarman, M Spina, A Gloghini, TF Schulz
Blood, The Journal of the American Society of Hematology 113 (6), 1213-1224, 2009
|Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases|
DV Ablashi, LG Chatlynne, JE Whitman, E Cesarman
Clinical microbiology reviews 15 (3), 439-464, 2002
|Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells|
SA Keller, EJ Schattner, E Cesarman
Blood, The Journal of the American Society of Hematology 96 (7), 2537-2542, 2000
|KSHV vFLIP is essential for the survival of infected lymphoma cells|
I Guasparri, SA Keller, E Cesarman
The Journal of experimental medicine 199 (7), 993-1003, 2004
|Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma|
J Ruan, P Martin, RR Furman, SM Lee, K Cheung, JM Vose, A LaCasce, ...
Journal of Clinical Oncology 29 (6), 690-697, 2011
|KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma|
A Chadburn, E Hyjek, S Mathew, E Cesarman, J Said, DM Knowles
The American journal of surgical pathology 28 (11), 1401-1416, 2004
|Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.|
EA Mesri, E Cesarman, L Arvanitakis, S Rafii, MA Moore, DN Posnett, ...
The Journal of experimental medicine 183 (5), 2385-2390, 1996